Sun Pharma, Philogen join hands to commercialise skin cancer drug in Europe ...Middle East

Business Standard - Economy
Sun Pharma, Philogen join hands to commercialise skin cancer drug in Europe
source : Business Standard ( Middle East ) () 44
Sun Pharmaceutical Industries on Tuesday said it has entered into a licensing pact with Philogen SpA to commercialise under-development skin cancer drug in Europe, Australia and New Zealand. The companies have come together to commercialise Philogen's speciality product Nidlegy, an anti-cancer biopharmaceutical currently in Phase III clinical trials, Sun Pharma said in a statement. Philogen, a Swiss-Italian firm, is developing it for the treatment of melanoma and non-melanoma skin cancers. Under the terms of the agreement, the Mumbai-based drug major will have exclusive rights to commercialise Nidlegy. Philogen will complete pivotal clinical trials for the product in Europe, pursue marketing

Hence then, the article about sun pharma philogen join hands to commercialise skin cancer drug in europe was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sun Pharma, Philogen join hands to commercialise skin cancer drug in Europe )

Apple Storegoogle play

Last updated :

Also on site :



Latest News

South Korean Company Signs $4 Billion Arms Deal with Poland

before 40 minute

Gold rises from two-week low, silver recovers

before 55 minute

Gambia: Govt Yet to Confirm Reported Tragic Deaths of 190 Migrants - Trade Minister

before hour & 16 minute

Kenya: 1 in 2 Kenyans Report Economy-Related Stress As 1 in 4 Suffer Mental Breakdown

before hour & 52 minute

Argentina’s Shale Boom Propels It Past Colombia in Oil Output

before 6 hours & 37 minute

ANGHAMI REPORTS H1 2025 FINANCIAL RESULTS; MARKED BY TOPLINE GROWTH AND TRANSFORMATIVE DEAL WITH WARNER BROS. DISCOVERY

before 8 hours & 22 minute

US Crude, Product Inventories Rise Again

before 8 hours & 22 minute

Big Oil Prepares for Leaner Prices and Harder Choices in 2026

before 8 hours & 37 minute

Pakistan-Afghanistan Fued Freezes $3 Billion in Annual Bilateral Trade

before 10 hours & 25 minute

Tatiana Schlossberg, environmental journalist and Kennedy scion, dies at 35

before 11 hour & 22 minute

Zillow report: Online research now shapes how most agent relationships begin

before 12 hour & 5 minute

Blockade Slows Exports but Tankers Still Drift Toward Venezuela

before 12 hour & 33 minute

NGD Infection Prevention Deploys NGD200 System to the Largest Medical Center in the Middle East

before 12 hour & 34 minute

Will Saudi Arabia/UAE Tensions Over Yemen Threaten OPEC Status Quo?

before 13 hour & 7 minute

Russia’s Pipeline Gas Sales to Europe Plunge to 50-Year Low

before 13 hour & 31 minute